Sex differences in Alzheimer’s disease: plasma MMP-9 and markers of disease severity
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-9193
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Sex differences in Alzheimer’s disease: plasma MMP-9 and markers of disease severity ; volume:14 ; number:1 ; day:2 ; month:11 ; year:2022 ; pages:1-12 ; date:12.2022
Alzheimer's research & therapy ; 14, Heft 1 (2.11.2022), 1-12, 12.2022
- Creator
-
Tsiknia, Amaryllis A.
Sundermann, Erin E.
Reas, Emilie T.
Edland, Steven D.
Brewer, James B.
Galasko, Douglas
Banks, Sarah J.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13195-022-01106-4
- URN
-
urn:nbn:de:101:1-2023011721000933675626
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tsiknia, Amaryllis A.
- Sundermann, Erin E.
- Reas, Emilie T.
- Edland, Steven D.
- Brewer, James B.
- Galasko, Douglas
- Banks, Sarah J.
- SpringerLink (Online service)
Other Objects (12)
Biological markers of Alzheimer's disease
MT5-MMP, just a new APP processing proteinase in Alzheimer’s disease?
Alzheimer’s Disease
Clinical importance in Alzheimer’s disease: effects of anchor agreement and disease severity
Cost of Patients with Alzheimer’s Disease in Spain According to Disease Severity
Neurophysiological Markers of Alzheimer’s Disease: Quantitative EEG Approach
Alzheimer's disease
Disease-modifying treatments in Alzheimer’s disease
Alzheimer’s disease as an inflammatory disease
Staging Disease Severity Using the Alzheimer’s Disease Composite Score (ADCOMS): A Retrospective Data Analysis
Substrates and functions of the Alzheimer’s disease proteases ADAM10, BACE1, and MT5-MMP
Serum neurofilament light levels correlate with severity measures and neurodegeneration markers in autosomal dominant Alzheimer’s disease
Biological markers of Alzheimer's disease
MT5-MMP, just a new APP processing proteinase in Alzheimer’s disease?
Alzheimer’s Disease
Clinical importance in Alzheimer’s disease: effects of anchor agreement and disease severity
Cost of Patients with Alzheimer’s Disease in Spain According to Disease Severity
Neurophysiological Markers of Alzheimer’s Disease: Quantitative EEG Approach
Alzheimer's disease
Disease-modifying treatments in Alzheimer’s disease
Alzheimer’s disease as an inflammatory disease
Staging Disease Severity Using the Alzheimer’s Disease Composite Score (ADCOMS): A Retrospective Data Analysis
Substrates and functions of the Alzheimer’s disease proteases ADAM10, BACE1, and MT5-MMP
Serum neurofilament light levels correlate with severity measures and neurodegeneration markers in autosomal dominant Alzheimer’s disease
Biological markers of Alzheimer's disease
MT5-MMP, just a new APP processing proteinase in Alzheimer’s disease?
Alzheimer’s Disease
Clinical importance in Alzheimer’s disease: effects of anchor agreement and disease severity
Cost of Patients with Alzheimer’s Disease in Spain According to Disease Severity
Neurophysiological Markers of Alzheimer’s Disease: Quantitative EEG Approach
Alzheimer's disease
Disease-modifying treatments in Alzheimer’s disease
Alzheimer’s disease as an inflammatory disease
Staging Disease Severity Using the Alzheimer’s Disease Composite Score (ADCOMS): A Retrospective Data Analysis
Substrates and functions of the Alzheimer’s disease proteases ADAM10, BACE1, and MT5-MMP